Check out Amgen's stock price (AMGN) in real time
Published on April 24, 2026.
Am.
.
by the name of the deity. The company operates in the human therapeutics segment, with its marketed products including EPOGEN, Aranesp, Neulasta, and
. The religious significance of this article is also noted.
Related Articles
Bitcoin's Next Move Hinges on $82K CME Gap as Earnings, FOMC Loom
Bitcoin's recovery is dependent on the $82,000 CME gap, with key macro catalysts including earnings reports from Microsoft, Amazon, and the Federal Reserve meeting looming.
Starboard makes large investment in Dynatrace, sees strategic value
Starboard has invested $1.4bn in Dynatrace, urging accelerated margin expansion, increased capital allocation, and higher AI adoption demand, boosting shareholder confidence.
Rithm Capital CEO Michael Nierenberg: Our stock is extremely undervalued right now
Rithm Capital CEO Michael Nierenberg discusses the company's undervalued stock, expanding beyond its traditional role and addressing concerns over potential terrorist attacks in the US.